U S LABORATORIES INC
3, 1999-02-23
TESTING LABORATORIES
Previous: U S LABORATORIES INC, 3, 1999-02-23
Next: U S LABORATORIES INC, 3, 1999-02-23





       FORM 3                                            OMB APPROVAL     
                                                                       
                                                    OMB Number        3235-0104
                                                    Expires  September 30, 1998
                                                    Estimated average burden
                                                    hours per response .....0.5


                     U.S. SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC. 20549

             INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
                                                                       
     Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
                       Section 17(a) of the Public Utility

         Holding Company Act of 1935 or Section 30(f) of the Investment
                               Company Act of 1940


(Print or Type Responses)
- --------------------------------------------       
1. Name and Address of Reporting Person              2. Date of Event-        
                                                        Requiring Statement
Baron             Mark                                   (Month/Day/Year)    
- --------------------------------------------                 2/23/99
(Last)          (First)           (Middle)                                 
                                                                             
2327 Fair Oak Court                                          
- -------------------------------------------- 
                (Street)                             3. IRS or Social Security
                                                        Number of Reporting  
Escondido, California 92026                             Person (Voluntary)
- -------------------------------------------- 
(City)          (State)            (Zip)


4.   Issuer Name and Ticker or Trading Symbol
                                             
          U.S. Laboratories Inc. (USLB)      
                                             
                                                                
5.   Relationship of Reporting Person                6. If Amendment, Date of 
     to Issuer                                          Original       
         (Check all applicable)                         (Month/Day/Year) 
                                                   
     |X|Director              [ ]10% Owner         
     [X]Officer (give         [ ]Other (specify   
                 title below)           below)    

          Executive Vice President

 7.   Individual or Joint/Group Filing
      (Check Applicable Line)                   
      |X|     Form filed by One Reporting Person   
      ___     Form filed by More than One Reporting
              Person             
                            

<TABLE>
<CAPTION>
                                Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security               2. Amount of             3. Ownership          4. Nature of Indirect Beneficial Ownership
   (Instr. 4)                         Securities               Form:  Direct         (Instr. 5)
                                      Beneficially             (D) or            
                                      owned                    Indirect          
                                      (Instr. 4)               (I) (Instr. 5)    
<S>                                <C>                      <C>                   <C>
Common Stock                       33,652                         D
                                                                                 
                                                                                 
                                                                                 
                                                                                 
                                                                                 
                                                                                 
                                                                                 
                                                                                 
                                                                                 
</TABLE>                                                                     
                          
Reminder:  Report on a separate line for each class of securities beneficially
           owned directly or indirectly.
*   If the form is filed by more than one reporting person, see instruction 
    5(b)(v).
<PAGE>
FORM 3 (continued)

<TABLE>
<CAPTION>
       TABLE II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

- --------------------------------- ----------------- ----------------------------------- ----------- ------------ -------------------
1. Title of Derivative Security   2. Date Exer-     3. Title and Amount of Securities   4. Conver-  5. Owner-      6. Nature of
   (Instr. 4)                        cisable and       Underlying                          sion or     ship           Indirect      
                                     Expiration        Derivative Security                 Exercise    Form of        Beneficial  
                                     Date              (Instr. 4)                          Price       Deri-          Ownership
                                     (Month/Day/Year)                                      of          vative         (Instr. 5)
                                                                                           Deri-       Security:
                                                                                           vative      Direct   
                                                                                           Security    (D) or   
                                                                                                       Indirect 
                                                                                                       (I)(Instr.
                                                                                                       5)
- --------------------------------- ----------------- ----------------------------------- ----------- ------------ -------------------
                                                                               Amount
                                  Date       Expira-                           or
                                  Exer-      tion              Title           Number
                                  cisable    Date                              of
                                                                               Shares
- --------------------------------- --------   -------- ------------------------ -------- ----------- ------------ -----------------
<S>                               <C>        <C>      <C>                      <C>      <C>         <C>          <C>
Incentive Stock Options           6/1/98*    11/10/03 Common Stock             16,666   $6.00          D
- --------------------------------- --------   -------- ------------------------ -------- ----------- ------------ -----------------
Incentive Stock Options           6/1/99*    11/10/03 Common Stock             13,334   $6.00          D
- --------------------------------- --------   -------- ------------------------ -------- ----------- ------------ -----------------
Warrant                              **        ***    Common Stock             10,000   $5.00          D
- --------------------------------- --------   -------- ------------------------ -------- ----------- ------------ -----------------

- --------------------------------- --------   -------- ------------------------ -------- ----------- ------------ -----------------

- --------------------------------- --------   -------- ------------------------ -------- ----------- ------------ -----------------

Explanation of Responses:

*If Mr. Baron's  employment  with the Company or its  Subsidiaries  changes from
full-time status or is interrupted by a leave of absence, the Board of Directors
may delay vesting for such period as it deems reasonably appropriate.

**  earlier  of (i) date on which  closing  price of a share of Common  Stock as
reported on the NASDAQ Small-Cap Market is greater than $10.00;  or (ii) date on
which audited financials of Company for fiscal year ended 12/31/98 or any fiscal
year  thereafter  reflect that the Company's  earnings per share of Common Stock
are at least twice the award of the "base period earning" of $841,041.

*** earlier of (i)30 days after Holder's  termination  for any reason other than
death,  disability  or  cause;  (ii)  90  days  after  Holder's  termination  of
employment due to death or disability;  (iii) Holder's termination of employment
for cause; or (iv) 11/01/01.
</TABLE>
                                   /S/ Mark Baron                      2/23/99
                             **  Signature of Reporting Person          Date
                                                       


**Intentional misstatements or omissions of 
  facts constitute Federal Criminal Violations. 
   See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).    


Note: File three copies of this Form, one of which must be manually signed.
      If space provided is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB Number.  


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission